Objective To synthesize the data available -on costs, efficiency and economies of scale and scope -for the six basic programmes of the UNAIDS Strategic Investment Framework, to inform those planning the scale-up of human immunodeficiency virus (HIV) services in lowand middle-income countries. Methods The relevant peer-reviewed and "grey" literature from low-and middle-income countries was systematically reviewed. Search and analysis followed Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Findings Of the 82 empirical costing and efficiency studies identified, nine provided data on economies of scale. Scale explained much of the variation in the costs of several HIV services, particularly those of targeted HIV prevention for key populations and HIV testing and treatment. There is some evidence of economies of scope from integrating HIV counselling and testing services with several other services. Cost efficiency may also be improved by reducing input prices, task shifting and improving client adherence. Conclusion HIV programmes need to optimize the scale of service provision to achieve efficiency. Interventions that may enhance the potential for economies of scale include intensifying demand-creation activities, reducing the costs for service users, expanding existing programmes rather than creating new structures, and reducing attrition of existing service users. Models for integrated service deliverywhich is, potentially, more efficient than the implementation of stand-alone services -should be investigated further. Further experimental evidence is required to understand how to best achieve efficiency gains in HIV programmes and assess the cost-effectiveness of each service-delivery model.
Introduction
To reach the Millennium Development Goals for human immunodeficiency virus (HIV) infection 1 and the targets of the Political Declaration on HIV and Acquired Immunodeficiency Syndrome (AIDS), 2 many low-and middle-income countries still need to scale up essential HIV services. Given the scarce financial resources available and competing donor priorities, methods to improve efficiency in the delivery of HIV services are gaining increased global attention. [3] [4] [5] [6] In general, an "efficient" HIV service cannot be improved without the further use of existing resources and cannot be maintained at its current level with fewer resources. The word "efficiency" has several dimensions when applied to HIV services. For example, economic theory distinguishes between efficiency from improving social welfare -the "allocative" efficiency that is often assessed in the health sector in terms of cost-effectiveness -and a more contained definition of efficiency that examines how best to use resources to provide individual services -the "technical" efficiency that is commonly assessed in terms of the unit costs of a service. Two potential areas for improving technical efficiency are service scale and service scope. "Economies of scale" are the reductions in the unit cost of a service that might be achieved when the volume of that service's provision is increased, whereas "economies of scope" are the reductions in the unit cost of a service that might be observed when that service is provided jointly with other services. 3, 4, [7] [8] [9] [10] [11] [12] There have been several recent reviews of the data available on the costs and cost-effectiveness of HIV interventions. 3, 4, [7] [8] [9] [10] [11] [12] [13] Most of these reviews were focused on allocative efficiency. 3, 4, 7, 9, 12 The results of the few previous studies on the technical efficiency of HIV services indicate not only that there is considerable variation -between service providers and between settings -in the unit costs of providing similar HIV services, but also that there is, in general, much scope for improving the technical efficiency of HIV services. 7, 9, 14 However, these reviews are outdated or were only partial in their coverage of possible interventions.
Given the current interest of policy-makers in reducing the costs of HIV services, there is now an urgent need to update and synthesize the data on the technical efficiency of HIV services. We therefore present here a systematic literature review of the costs of the six basic programmatic activities of the Strategic Investment Framework of the Joint United Nations Programme on HIV/AIDS (UNAIDS): antiretroviral therapy (ART) and counselling and testing; "key-population" programmes -that is, programmes that target groups of individuals who are at particularly high risk of HIV infection; condom distribution and social marketing; voluntary medical male circumcision; programmes to eliminate HIV infections among children and to keep their mothers alive; and programmes of behaviour-change communications targeted at young adults and the general population. 15 
Methods

Search strategy and selection criteria
We conducted a systematic review of the peer-reviewed and "grey" literature on HIV services in low-and middle-income countries by following the search and analysis process recommended in the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. 16 The PubMed and Eldis databases and the Cochrane library were searched, using AIDS, HIV, acquired immunodeficiency syndrome, cost, cost analysis, efficiency, economies of scale and economies of scope as the search terms. Searches were limited to English-language articles published between January 1990 and October 2013. Manual searches of the web sites of key organizations were also carried out to identify grey literature and minimize the risk of publication bias (Fig. 1 ). 17 The World Bank's definitions were used to categorize countries as low-or middle-income. 18 Although conference abstracts, editorials, commentaries and "letters to the editor" were used to identify related studies -through a "snowballing" process -any data found only in such publications were excluded from the systematic review. Studies of mathematical models that provided no primary data on costs were also excluded. Bibliographies and previous systematic reviews were examined to identify additional studies of relevance. Authors were contacted directly if the full text of a published paper, unpublished paper or report was not available to us. Two researchers screened the identified citations, reviewed the full texts of potentially eligible articles and selected the final articles for inclusion. Data were extracted by one researcher before being checked by another researcher. Whenever there was uncertainty or disagreement about the inclusion of a study, the authors discussed the study until a consensus was reached.
Data on the unit costs of the HIV services of interest were available for seven upper-middle-income countries, 14 lower-middle-income countries and 12 low-income countries. Most of the included studies were categorized as cost analyses but cost data were also extracted from cost-effectiveness and cost-benefit analyses, resource-needs estimations and broad evaluation studies. Authors of only 30 of the included studies undertook sensitivity analyses to assess the levels of uncertainty in their cost estimates.
Data extraction and quality of studies
The quality of studies was assessed using Drummond's checklist. 19 Additional criteria for the assessment of study quality were included whether all relevant costs were included, the source of the cost estimates, whether a sensitivity analysis was conducted and, if so, what type of sensitivity analysis was used, and the scale of the study -in terms of the number of sites for which costings were made. As we wished to evaluate the overall quality of studies, we included all studies with some empirical basis, irrespective of their quality. However, we took study quality into account when reporting the strength of the evidence.
We used the unit costs of service provision -at the health-provider level -as our primary comparative statistic. However, we also noted whether the data from each study included other, "above-service" costs, such as the outof-pocket expenses of clients using a particular HIV service. We took a narrative approach in our data synthesis, as has been recommended for reviews of health systems and organizational interventions. 17 For the purposes of the systematic review, all reported costs were adjusted to United States dollar (US$) values for the year 2011.
Results
Summary of studies
We identified 7108 unique citations of potential relevance and selected 131 of these for full-text review (Fig. 1 ). Overall, 82 studies met the inclusion criteria: 65 reported in peer-reviewed journals and 17 reported in the grey literature (Table 1 ). Most (n = 63) of the included studies were classified as fully empirical and 34 included all relevant costs. Costing methods varied between studies but included a "top-down" approach, a "bottom-up" approach and a combination of both of these approaches. Together, the 82 included studies covered 92 unit-cost analyses that related to ART (n = 34), key population programmes (n = 14), HIV counselling and testing (n = 22), 
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Efficiency and costs in core HIV services Mariana Siapka et al. programmes to eliminate HIV infections among children and to keep their mothers alive (n = 10), male circumcision (n = 7), condom distribution (n = 4) or behaviour-change communications (n = 1). Many studies were excluded because they did not relate to core HIV or AIDS services, were not conducted in a low-or middle-income country or did not report empirical costs. Table 2, Table 3 , Table 4 , Table 5 , Table 6 , Table 7 and Table 8 provide summaries of costs reported in the literature that we reviewed. Further details can be found in Table 9 , Table 10 , Table 11, Table 12 , Table 13 , Table 14 and Table 15 (available at: http://www.who. int/bulletin/volumes/92/7/13-127639) and in Appendix A (available at: http:// researchonline.lshtm.ac.uk/1620414/). The costs reported in the included studies were generally restricted to the unit costs of one or more HIV services at site level. The reporting of "above-service" costs varied and was always only partial. Most studies included the costs of activities such as training and supervision, 36, 37 but the costs of several other activities, such as the maintenance of a drugs supply chain, transportation and technical support, were rarely included.
Economies of scale
The key findings from 40 studies found exploring costs and economies of scale are summarized in Appendix A. Only nine of these studies had sufficiently large samples to apply econometric methods to explore any associations between scale and costs. 23, 69, 74, 75, [77] [78] [79] 93, 96 Most of these studies were focused on HIV prevention among key populations. None covered condom distribution, male circumcision or interventions that were targeted at men who have sex with men. Scale was often found to explain statistically significant proportions of the variability seen in unit costs -including 48%, 42%, 28-83%, 25-88% and 45-96% of such variability in an ART programme, 23 a programme for the elimination of mother-to-child transmission of HIV infection, 96 HIV counselling and testing, 69, 96 and programmes targeting (continues. . .) sex workers 69, 74, 75, 77, 79, 96 and people who inject drugs, 96 respectively. The only evidence of a diseconomy of scale 96 that we found in the results of econometric studies was the observation that a quadratic function provided a fairly good fit to the cost data observed in one such investigaton. 91 In several descriptive studies, unit costs for HIV services appeared to be influenced by the link between scale and the achievement of optimal staff workloads. 23, 37, 55, 64 As a programme ages, unit costs may either increase 79 or -if the programme scales up over time -decrease. 20, 27, 73 Any cost reductions that occur during scale-up may result from "learning by doing" and task shifting. 20, 32, 39, 43 
Economies of scope
We reviewed 23 studies that reported both unit costs and economies of scope, including 12 studies 20, 24, 31, 33, 46, 52, 63, 64, 69, 88, 91, 95 that were not included in the earlier review by Sweeney et al. (2012) . 9 Most of the 23 studies related to HIV counselling and testing (n = 18) or ART (n = 3) but we also analysed single studies on three other types of programme: behaviourchange communications, male circumcision and the elimination of mother-tochild transmission (Appendix A).
Although the integration of voluntary HIV counselling and testing with other health services was found to improve quality, increase the utilization of services and reduce the cost per visit in some programmes, 57, 61, 70 it was found to increase costs in other programmes. 20, 95 Compared with the costs of stand-alone services, the integration of HIV counselling and testing with other health services has been reported to reduce unit costs -of the counselling and testingby between 17% and 79%. 9, 57, 59, 61, 63, 64, 67, 70, 95 In terms of the unit costs per HIV infection identified, provider-initiated voluntary testing and counselling was found to be less than half as expensive as client-initiated counselling and testing. 64 When counselling and testing were integrated with other health services, a strong and functioning referral system was found to be important for creating demand. 9, 24, 25, 29, 31, 33, 35, 45, 63, 67, 69, 70 Other pathways to improve efficiency Our systematic review revealed evidence of many other determinants of costs and j Based on both first-and second-line regimens. k Excluding first month of initiation. l Cost of ART was assumed to be the mean cost of first-line drugs, which was estimated -in the values for 2007 -at US$ 237.50 per patient-year. m Mean costs of home-and facility-based care. n Mean for first year ART across all drug regimens and facility types. o Based on a mean number of 1000 people treated per year and annual provision of services to 14 000. p Based on the assumption that 78% of patients were on the first-line regimen. q Mean annual cost of first 3 years of post-ART care. r Mean value across different CD4+ T-lymphocyte count groups. 53 Zimbabwe 0.97 0.16 Africa -western and central Söderlund et al. (1993) 53 Cameroon 0.54 Söderlund et al. (1993) 53 Democratic Republic of the Congo 0.18 Söderlund et al. (1993) 53 Ghana 0.13 Asia and Pacific Dandona et al. (2010) 56 India 1.54 Söderlund et al. (1993) 53 Indonesia 0.07 Caribbean Söderlund et al. (1993) 53 Dominican Republic 0.21 Latin America Söderlund et al. (1993) 53 Bolivia 0.72 Söderlund et al. (1993) 53 Brazil 1.12 Söderlund et al. (1993) 53 Côte d'Ivoire 0.24 Söderlund et al. (1993) 53 Ecuador 0.29 Söderlund et al. (1993) 53 Mexico 0.41 Northern Africa and Middle East Söderlund et al. (1993) 53 Morocco 0.81 efficiency besides economies of scale and scope (Appendix A). Although task shifting was observed to reduce costs, there were concerns that it might also reduce service quality. 30 In India, costs incurred above the level of service delivery have been reported to account for 35 to 46% of the unit costs of HIV prevention. 43 Loss to follow-up may be a key source of inefficiency in ART programmes -resulting in a 15 to 55% increase in the unit costs per patient treated. 29, 31, 33 We found limited evidence of possible gains from targeting specific groups of patients and clients 4, 58, 60, 63, 64, 67 and little examination of the trade-off between the costs of targeting and efficiency gains. We also found no studies in which the cost efficiency of providing more intense services to a particular group was compared with that of providing a minimal service to a larger population group.
Discussion
There is a growing evidence base on the costs of delivering ART, HIV counselling and testing, interventions for condom distribution and the prevention of mother-to-child transmission of HIV, voluntary medical male circumcision and key-population programmes in lowand middle-income countries. While some of the differences observed in the unit costs are likely to be explained by environmental factors, the wide variation indicates there is general room for improvement in the technical efficiency of HIV services.
In our systematic review, evidence of economies of scale in all of the studies enabled a robust examination of the relationship between scale and costs. HIV services should therefore be focused on sites with sufficient demand for such services. In the "free market", economies of scale generally lead to mergers that create large-scale providers and large production units. However, where populations are dispersed, a balance needs to be sought between provider costs and the costs incurred by clients as they access care. Several of the studies that we reviewed demonstrated the high health care costs for patients. [36] [37] [38] 40, 58 The burden of these "client-side" costs may need to be shifted to service providersthrough the provision of more accessible services or, possibly, by reimbursing each patient's travel costs. Such changes may limit the extent to which economies of scale are realized. Although the high costs to patients of accessing care might be reduced by providing mobile or home-based services, there is little evidence to show that the implementation of such services reduces provider costs. Some degree of trade-off may have to be made between client and provider costs. [35] [36] [37] Unit costs may often be reduced by increasing staff workloads. 28, 31, 32, 36, 39, 47, 64 In optimizing staff workloads, supply of staff has to be matched with the demand for services. On the supply side, the extent to which staffing levels are fixed is often either an artefact of human-resource planning -in which staffing complements are defined using norms, irrespective of the workload or demand per site -or a reflection of minimum clinical requirements. In many settings, the creation of demand -where there is a need -may be the only way to optimize workloads. Demand may be increased by identifying new clients, improving adherence and reducing loss to follow-up. 59, 99 Within staffing norms, there may still be flexibility within staffing allocations at site level. Site or programme managers must be provided with the data and means to allocate staff in a responsive manner. Task shifting may reduce both provider costs -by lowering the cost of salaries and increasing flexibility around any minimum staffing requirements 101 -and client costs -by allowing services to be delivered from sites that are relatively close to the 
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clients and run by lower-level staff. 102 In the future, new technologies, such as the non-surgical PrePex method of circumcision, may further reduce the need for high-level clinical staff. 30, 32, 66, 87 However, the current evidence of the impact on task shifting on costs remains inconsistent 93 and there remain concerns that task shifting may lead to poor morale among lower-paid staff and lower service quality. 85, 102 Our current findings on economies of scale generally support the assumptions made in the UNAIDS Strategic Investment Framework on the existence of economies of scale with programmes of HIV counselling and testing and HIV prevention for key populations. However, economies of scale at the programme level tend to differ from those at site level. The evidence presented here refers to the relationship between costs and site scale. Although costs incurred above the service level are likely to be fixed, economies of scale derived from sitelevel costings may often still underestimate the corresponding programmatic economies of scale. 24, 37, 43, 56 In some cases, programmes may suffer from diseconomies of scale as they increase the number of service providers to reach groups that are particularly hard to reach. We found almost no evidence of diseconomies of scale 56, 61, 81 but the relevant evidence base was relatively small. It should not be assumed that diseconomies of scale do not exist.
While there is a broad evidence base on the cost-effectiveness of some integrated HIV services, 9 there is con-siderably less information available on the corresponding economies of scope. 9, 63, 67, 70, 95 The economies of scope that have been reported may only represent the indirect effects of economies of scale -that is, integration may simply have brought HIV services to new clients rather than improved efficiency through the joint provision of services. 70 Most of the other factors that have been found to influence unit costs are also potentially within the control of managers of HIV programmes. Reductions in commodity prices, especially those for first-and second-line antiretroviral drugs, have the potential to yield substantial cost savings. Such reductions may be achieved via revised national tenders, joint procurement, improved forecasting, and process efficiency and transparency. 33, 45, 46, 48 Cost savings achieved by reducing the price of second-line therapy will continue to be critical in low-and lower-middleincome countries, where patients are particularly likely to switch to secondline regimens over time.
Few of the studies that we reviewed incorporated any analysis of the quality of service provision. However, where quality and costs were jointly examined, cost reduction often led to reduced quality. 26, 29, 33, 35, 37, 40, 46, 92 In a large review of 15 ART programmes in Africa, Asia and Latin America, it was found that increases in the scale of a programme led to increases in the rates of loss to follow-up. 103 Compared with small programmes, large-scale programmes were less likely to follow up patients actively. 103 Unfortunately, little is known about the potential "cost-quality tradeoff " of the alternative service models that may be adopted to reduce unit costs, such as reducing the number of visits required for ART monitoring. Support for managers at the site and district level -for example, to allow costs to be monitored and "blueprint" approaches to be avoided -may be key to ensuring that efforts to improve efficiency do not damage staff morale or service quality. 30, 57, 58, 64 When setting national and international cost benchmarks, attention must also be taken not to create perverse incentives by emphasizing measurable costs rather than the more intangible aspects of service quality.
We were unable to find much published information on the unit costs of several of the key interventions included in the UNAIDS Strategic Investment Framework. Most notably, there is a dearth of data on the costs of ART for key populations, condom distribution in general, HIV counselling and testing beyond Africa, key population interventions outside India, and large-scale programmes for the prevention of motherto-child transmission of HIV and male circumcision. Most of the relevant studies in which economies of scale or scope were investigated had small samples. It remains unclear whether economies of scale or scope vary by provider type or other site or service characteristics. Studies that include the full range of costs and uncertainty analysis of cost estimates and have samples large enough to show all cost variation in detail remain rare. There is also a distinct lack of experimental studies that have been designed to detect the sources of inefficiency. Despite these limitations, there are signs of recent improvements in the costing of HIV services. Most of our main findings were derived from studies conducted over the last five years. There is also some evidence that cost reductions are already being achieved as HIV programmes mature 93 and, in the future, there may be further scope for efficiency gains as new technologies and service models are developed.
Large-scale costing studies that cover the full range of HIV services are required. Empirical costing studies of activities above the service level are also needed to provide insights into approaches for optimizing programme costs. In the future, experimental studies -especially on actions to enhance planning and management capacity, the utilization of human resources, financial and information systems, demand generation and service integrationcould allow efficiency to be improved. If essential HIV services are to be made cheaper and sustainable, the policymakers involved with HIV will probably have to engage with those involved in improving the efficiency and capacity of general systems for health care and community support.
In conclusion, the general efficiency of HIV services must be improved if core interventions are to be successfully scaled up in environments where resources are scarce. At site level, economies of scale can often be made. The integration of HIV services with other health services may also reduce costs. Further studies are required to determine the best ways of improving the efficiency of HIV services at site level and the likely impact of such improvements on the national costs of HIV services. ■ Funding: This work was supported by UNAIDS.
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Résumé
Est-il possible de faire des économies et d'obtenir des gains en termes d'efficacité dans les services anti-VIH? Un examen systématique des éléments de preuve dans les pays à revenu faible et intermédiaire
Objectif Synthétiser les données disponibles -sur les coûts, l' efficacité et les économies d' échelle et d' envergure -pour les six programmes de base du Cadre d'investissement stratégique de l'ONUSIDA, afin d'informer les responsables de la planification de l' élargissement des services de lutte contre le virus de l'immunodéficience humaine (VIH) dans les pays à revenu faible et intermédiaire. Méthodes Des pairs des pays à revenu faible et intermédiaire ont systématiquement examiné la documentation pertinente «grise» et révisée. La recherche et l'analyse ont appliqué les directives PRISMA (éléments de rapport préférés pour les examens systématiques et les méta-analyses). Résultats Des 82 études de coûts et de rendement empiriques identifiées, neuf fournissaient des données sur les économies d' échelle. L' échelle expliquait en grande partie la variation des coûts de plusieurs services anti-VIH, en particulier ceux de la prévention ciblée du VIH dans les populations clés et ceux du dépistage et du traitement du VIH. Il existe certaines preuves d' économies d' envergure, résultant de l'intégration de services de conseil et de dépistage du VIH avec plusieurs autres services. La rentabilité peut également être améliorée en réduisant les prix des intrants, en déléguant des tâches et en améliorant l'adhésion des clients. Conclusion Les programmes anti-VIH doivent optimiser l'échelle de prestation des services pour être efficaces. Les interventions qui peuvent améliorer le potentiel des économies d' échelle comprennent l'intensification des activités de création de la demande, la réduction des coûts pour les utilisateurs des services, l' expansion des programmes existants plutôt que la création de nouvelles structures, et la réduction de l'attrition des utilisateurs des services existants. Les modèles de prestation des services intégrés, qui sont potentiellement plus efficaces que la mise en oeuvre de services autonomes, doivent faire l'objet d' études approfondies. D'autres éléments de preuve expérimentaux sont requis pour trouver la meilleure façon d' obtenir des gains en termes d' efficacité dans les programmes anti-VIH, mais aussi pour évaluer le rapport coût-efficacité de chaque modèle de prestation de services. 
‫ملخص‬ ‫استعراض‬ ‫البرشي؟‬ ‫املناعي‬ ‫العوز‬ ‫فريوس‬ ‫خدمات‬ ‫يف‬ ‫الكفاءة‬ ‫ومكاسب‬ ‫التكاليف‬ ‫وفورات‬ ‫لتحقيق‬ ‫نطاق‬ ‫يوجد‬ ‫هل‬ ‫الدخل‬ ‫املتوسطة‬ ‫والبلدان‬ ‫الدخل‬ ‫املنخفضة‬ ‫البلدان‬ ‫من‬ ‫املستمدة‬ ‫نات‬ ّ ‫للبي‬ ‫منهجي‬
Resumen ¿Hay margen para el ahorro de costes y el aumento de la eficacia en los servicios de VIH? Un examen sistemático de la evidencia de países con ingresos bajos y medios
Objetivo Sintetizar los datos disponibles sobre los costes, la eficacia y las economías de escala y alcance de los seis programas básicos del Marco Estratégico de Inversión de ONUSIDA e informar a los responsables de la planificación de la ampliación de los servicios del virus de la inmunodeficiencia humana (VIH) en países con ingresos bajos y medios. Métodos Se examinó sistemáticamente la literatura revisada por homólogos y «gris» relevante de países con ingresos bajos y medios. La búsqueda y el análisis se realizaron según las pautas de Ítems de Informe Preferidos para Evaluaciones Sistemáticas y Meta-Análisis. Resultados De los 82 estudios empíricos sobre costes y eficacia identificados, nueve de ellos proporcionaron datos sobre las economías de escala. La escala explicó gran parte de la variación de los costes en numerosos servicios de VIH, en particular en aquellos dirigidos a la prevención del VIH en poblaciones clave y las pruebas y el tratamiento del VIH. Hay alguna evidencia de economías de alcance que integran el asesoramiento sobre el VIH y los servicios de pruebas con muchos otros servicios. También sería posible aumentar la costo-eficacia mediante la reducción de los precios de los insumos, la delegación de funciones y la mejora de la fidelidad de los clientes. Conclusión Los programas de VIH deben optimizar la escala de prestación de servicios para conseguir ser eficaces. Las intervenciones pueden mejorar el potencial de las economías de escala, por ejemplo, al intensificar las actividades de promoción de demanda, reducir los costes para los usuarios, expandir los programas existentes en lugar de crear estructuras nuevas y reducir el abandono de los usuarios existentes de los servicios. Se deben investigar más los modelos de prestación de servicios integrados, que son posiblemente más eficaces que la implementación de servicios independientes. Es necesario obtener más evidencia experimental para comprender cómo es posible lograr mayor eficacia en los programas de VIH y evaluar la costo-eficacia de cada modelo de prestación de servicios.
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Efficiency and costs in core HIV services Mariana Siapka et al. The four models investigated were "standalone" (client-initiated HCT at free-standing centres), "hospital-based" (provider-initiated HCT via an opt-out approach for inpatients and outpatients), "door-to-door" (home-based, provider-initiated HCT via mobile teams) and "household-member" (same as door-to-door 
